Correlation Between Virax Biolabs and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Puma Biotechnology, you can compare the effects of market volatilities on Virax Biolabs and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Puma Biotechnology.
Diversification Opportunities for Virax Biolabs and Puma Biotechnology
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Virax and Puma is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Virax Biolabs and Puma Biotechnology
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 2.85 times more return on investment than Puma Biotechnology. However, Virax Biolabs is 2.85 times more volatile than Puma Biotechnology. It trades about 0.04 of its potential returns per unit of risk. Puma Biotechnology is currently generating about 0.0 per unit of risk. If you would invest 250.00 in Virax Biolabs Group on September 14, 2024 and sell it today you would lose (95.00) from holding Virax Biolabs Group or give up 38.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Puma Biotechnology
Performance |
| Timeline |
| Virax Biolabs Group |
| Puma Biotechnology |
Virax Biolabs and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Puma Biotechnology
The main advantage of trading using opposite Virax Biolabs and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Virax Biolabs vs. Puma Biotechnology | Virax Biolabs vs. Iovance Biotherapeutics | Virax Biolabs vs. Day One Biopharmaceuticals | Virax Biolabs vs. Inozyme Pharma |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |